China Medical Healthcare Stock Net Income
| COLRF Stock | USD 0.08 0.00 0.00% |
China Medical HealthCare technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
China Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing China Medical's valuation are provided below:China Medical HealthCare does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. China |
China Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to China Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of China Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in China Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding China Medical HealthCare or generate 0.0% return on investment in China Medical over 90 days. China Medical HealthCare Group Limited, an investment holding company, primarily operates hospitals in the Peoples Repub... More
China Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure China Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess China Medical HealthCare upside and downside potential and time the market with a certain degree of confidence.
China Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as China Medical's standard deviation. In reality, there are many statistical measures that can use China Medical historical prices to predict the future China Medical's volatility.China Medical HealthCare Backtested Returns
We have found three technical indicators for China Medical HealthCare, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and China Medical are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
China Medical HealthCare has no correlation between past and present. Overlapping area represents the amount of predictability between China Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of China Medical HealthCare price movement. The serial correlation of 0.0 indicates that just 0.0% of current China Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, China Medical HealthCare reported net income of (137.3 Million). This is 140.23% lower than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The net income for all United States stocks is 124.05% higher than that of the company.
China Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Medical could also be used in its relative valuation, which is a method of valuing China Medical by comparing valuation metrics of similar companies.China Medical is currently under evaluation in net income category among its peers.
China Fundamentals
| Return On Equity | -0.0597 | |||
| Return On Asset | 0.0027 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 153.44 M | |||
| Shares Outstanding | 14.48 B | |||
| Shares Owned By Insiders | 75.25 % | |||
| Shares Owned By Institutions | 13.85 % | |||
| Price To Book | 0.30 X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 1.46 B | |||
| Gross Profit | 260.23 M | |||
| EBITDA | 52.31 M | |||
| Net Income | (137.3 M) | |||
| Cash And Equivalents | 544.61 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 316.41 M | |||
| Debt To Equity | 0.58 % | |||
| Current Ratio | 0.87 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | 219.42 M | |||
| Earnings Per Share | (0) X | |||
| Number Of Employees | 2.54 K | |||
| Beta | 0.93 | |||
| Market Capitalization | 110.68 M | |||
| Total Asset | 3.49 B | |||
| Net Asset | 3.49 B |
About China Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Medical HealthCare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Medical HealthCare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in China Pink Sheet
China Medical financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medical security.